NAASO GUIDELINES ON ANTI-OBESITY DRUGS EXPECTED BY NOVEMBER

NAASO GUIDELINES ON ANTI-OBESITY DRUGS EXPECTED BY NOVEMBER, the North American Association for the Study of Obesity reports. The "Guidelines for the Development, Approval and Use of Drugs to Treat Obesity" are under review by the society and should be finalized in four to six weeks, NAASO said. They will be published in the society's Journal of Obesity Research. The guidelines were co-authored by NAASO President Xavier Pi-Sunyer, MD, St. Luke's Hospital, and Judy Stem, University of California-Davis.